ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

The Journal of Urology ◽

10.1097/00005392-200012000-00029 ◽

2000 ◽

pp. 1992-1995 ◽

Author(s):

C. PALMBERG ◽

P. KOIVISTO ◽

L. KAKKOLA ◽

T. L. J. TAMMELA ◽

O. P. KALLIONIEMI ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Advanced Prostate Cancer ◽

Receptor Gene ◽

Androgen Receptor Gene ◽

Second Line ◽

Second Line Therapy ◽

Combined Androgen Blockade ◽

Line Therapy ◽

Androgen Blockade

Download Full-text

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

The Journal of Urology ◽

10.1016/s0022-5347(05)66935-2 ◽

2000 ◽

Vol 164 (6) ◽

pp. 1992-1995 ◽

Author(s):

C. PALMBERG ◽

P. KOIVISTO ◽

L. KAKKOLA ◽

T.L.J. TAMMELA ◽

O.P. KALLIONIEMI ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Advanced Prostate Cancer ◽

Receptor Gene ◽

Androgen Receptor Gene ◽

Second Line ◽

Second Line Therapy ◽

Combined Androgen Blockade ◽

Line Therapy ◽

Androgen Blockade

Download Full-text

Androgen Receptor Gene Amplification in a Recurrent Prostate Cancer after Monotherapy with the Nonsteroidal Potent Antiandrogen Casodex (Bicalutamide) with a Subsequent Favorable Response to Maximal Androgen Blockade

European Urology ◽

10.1159/000474453 ◽

1997 ◽

Vol 31 (2) ◽

pp. 216-219 ◽

Author(s):

C. Palmberg ◽

P. Koivisto ◽

E. Hyylinen ◽

J. Isola ◽

T. Visakorpi ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Gene Amplification ◽

Receptor Gene ◽

Androgen Receptor Gene ◽

Recurrent Prostate Cancer ◽

Maximal Androgen Blockade ◽

Androgen Blockade

Download Full-text

Androgen receptor (AR) activation levels on circulating tumor cells (CTCs) to predict response to second-line therapy in castration-resistant prostate cancer (CRPC)

Science-Business eXchange ◽

10.1038/scibx.2012.1168 ◽

2012 ◽

Vol 5 (44) ◽

pp. 1168-1168

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Download Full-text

MP52-12 COMPARISON OF ALTERNATIVE ANDROGEN RECEPTOR-AXIS-TARGETED AGENT (ARATA) VERSUS DOCETAXEL AS SECOND-LINE THERAPY FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER INITIAL ARATA IN REAL-WORLD CLINICAL PRACTICE IN JAPAN

The Journal of Urology ◽

10.1016/j.juro.2018.02.1663 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Yuto Matsushita ◽

Keita Tamura ◽

Takayuki Sugiyama ◽

Hideaki Miyake

Keyword(s):

Prostate Cancer ◽

Clinical Practice ◽

Androgen Receptor ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy ◽

Download Full-text

Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancer: Relation to Antiandrogen Withdrawal Syndrome

The Prostate ◽

10.1002/1097-0045(199609)29:3<153::aid-pros2990290303>3.0.co;2-5 ◽

1996 ◽

Vol 29 (3) ◽

pp. 153-158 ◽

Author(s):

Hiroyoshi Suzuki ◽

Koichiro Akakura ◽

Akira Komiya ◽

Sara Aida ◽

Susumu Akimoto ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Withdrawal Syndrome ◽

Advanced Prostate Cancer ◽

Receptor Gene ◽

Androgen Receptor Gene

Download Full-text

Second-Line Antiandrogen Therapy in Japanese Men with Advanced Prostate Cancer Relapsed after Primary Combined Androgen Blockade: Who Will Benefit from Second-Line Hormonal Therapy?

Urologia Internationalis ◽

10.1159/000318056 ◽

2010 ◽

Vol 85 (4) ◽

pp. 491-497

Author(s):

Minoru Kobayashi ◽

Kazumi Suzuki ◽

Shinsuke Kurokawa ◽

Masayuki Yuzawa ◽

Tatsuo Morita

Keyword(s):

Prostate Cancer ◽

Hormonal Therapy ◽

Advanced Prostate Cancer ◽

Second Line ◽

Japanese Men ◽

Combined Androgen Blockade ◽

Antiandrogen Therapy ◽

Androgen Blockade

Download Full-text

Comparison of Alternative Androgen Receptor-axis-targeted Agent (ARATA) and Docetaxel as Second-line Therapy for Patients With Metastatic Castration-resistant Prostate Cancer With Progression After Initial ARATA in Real-world Clinical Practice in Japan

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2017.11.007 ◽

2018 ◽

Vol 16 (3) ◽

pp. 219-225 ◽

Author(s):

Hideaki Miyake ◽

Takayuki Sugiyama ◽

Ryota Aki ◽

Yuto Matsushita ◽

Keita Tamura ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Practice ◽

Androgen Receptor ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy ◽

Download Full-text

More long-term research is needed on cryosurgery as a second-line therapy for prostate cancer

PsycEXTRA Dataset ◽

10.1037/e556952006-011 ◽

1999 ◽

Keyword(s):

Prostate Cancer ◽

Second Line ◽

Second Line Therapy ◽

Download Full-text

Cabazitaxel and prednisone as second-line therapy of metastatic, castration-resistant prostate cancer

Community Oncology ◽

10.1016/s1548-5315(11)70531-9 ◽

2010 ◽

Vol 7 (12) ◽

pp. 540-542 ◽

Author(s):

Jame Abraham

Keyword(s):

Prostate Cancer ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Download Full-text

Combined Androgen Blockade Is the Treatment of Choice for Patients with Advanced Prostate Cancer: The Argument For

European Urology ◽

10.1159/000473836 ◽

1996 ◽

Vol 29 (2) ◽

pp. 34-36 ◽

Author(s):

F.M.J. Debruyne

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Combined Androgen Blockade ◽

Androgen Blockade

Download Full-text